Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 8INDUSTRY 4NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasm Metastasis 3Breast Neoplasms 3Prostatic Neoplasms 2Osteoporosis 2Neoplasms, Plasma Cell 1Multiple Myeloma 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Zoledronic Acid 2Vitamin D 1Progestins 1Progesterone 1Observation 1Linseed Oil 1Letrozole 1Hormone Replacement Therapy 1Estrogens, Conjugated (USP) 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Alendronate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Osteoporosis × Zoledronic Acid × Clear all
NCT00049452 2014-01-06

Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
120 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00114270 2013-03-26

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density

National Cancer Institute (NCI)

Phase NA Completed
Breast

Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡